Watson's World
By Jesse Reynolds
| 10. 24. 2007
Nobel Prize season has come to an awkward end. Once a day during last week, we heard announcements of the winners in the six fields, including a high-profile award to Al Gore. The recipients will forever be honored to include the word "laureate" in their biographies.
But a few days later, the most prominent Nobel scientist winning scientist deeply marred his reputation. James Watson, who in 1962 won the prize for his elucidation of DNA's structure, unequivocally stated in an interview with the United Kingdom's Sunday Times that black people are less intelligent than whites. Speaking on development programs in Africa, Watson lamented that "all our social policies are based on the fact that their intelligence is the same as ours - whereas all the testing says not really… [P]eople who have to deal with black employees find [equality] is not true."
It may be tempting to dismiss this stunning utterance as the sloppy, irrelevant ramblings of a once-great scientist who is well past his prime. But Watson is a remarkably influential figure who has consistently reduced behavior to biology...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...